Phosphodiesterase 5 attenuates the vasodilatory response in renovascular hypertension
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
In: PLoS one, 8, 11, Artikel e80674, S. e80674-1-e80674-13
- Ereignis
-
Veröffentlichung
- (wo)
-
Bochum
- (wer)
-
Ruhr-Universität Bochum
- (wann)
-
2013
- Urheber
-
Stegbauer, Johannes
Friedrich, Sebastian
Potthoff, Sebastian Alexander
Schulte, Kathrin
Cortese-Krott, Miriam Margherita
Quack, Ivo
Rump, Lars Christian
Koesling, Doris
Mergia, Evanthia
- URN
-
urn:nbn:de:hbz:294-72699
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:44 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Stegbauer, Johannes
- Friedrich, Sebastian
- Potthoff, Sebastian Alexander
- Schulte, Kathrin
- Cortese-Krott, Miriam Margherita
- Quack, Ivo
- Rump, Lars Christian
- Koesling, Doris
- Mergia, Evanthia
- Ruhr-Universität Bochum
Entstanden
- 2013
Ähnliche Objekte (12)
Phosphodiesterase 10A upregulation contributes to pulmonary arterial hypertension
Role of Phosphodiesterase 5 and Cyclic GMP in Hypertension
Predictors of the response to phosphodiesterase-5 inhibitors in pulmonary arterial hypertension: an analysis of the Spanish registry
Inhibition of phosphodiesterase 5 restores endothelial function in renovascular hypertension
Mutant phosphodiesterase 3A protects from hypertension-induced end-organ damage
Lung vasodilatory response to inhaled iloprost in experimental pulmonary hypertension: amplification by different type phosphodiesterase inhibitors
Effect of a phosphodiesterase-5A (PDE5A) gene polymorphism on response to sildenafil therapy in canine pulmonary hypertension
Pulmonary hypertension attenuates the dynamic preload indicators increase during experimental hypovolemia
Alamandine attenuates hypertension and cardiac hypertrophy in hypertensive rats
Phosphodiesterase Langerhansscher Inseln
The inhaled phosphodiesterase 4 inhibitor GSK256066 reduces allergen challenge responses in asthma
Dual phosphodiesterase type 5 inhibitor therapy for refractory pulmonary arterial hypertension: a pilot study
Phosphodiesterase 10A upregulation contributes to pulmonary arterial hypertension
Role of Phosphodiesterase 5 and Cyclic GMP in Hypertension
Predictors of the response to phosphodiesterase-5 inhibitors in pulmonary arterial hypertension: an analysis of the Spanish registry
Inhibition of phosphodiesterase 5 restores endothelial function in renovascular hypertension
Mutant phosphodiesterase 3A protects from hypertension-induced end-organ damage
Lung vasodilatory response to inhaled iloprost in experimental pulmonary hypertension: amplification by different type phosphodiesterase inhibitors
Effect of a phosphodiesterase-5A (PDE5A) gene polymorphism on response to sildenafil therapy in canine pulmonary hypertension
Pulmonary hypertension attenuates the dynamic preload indicators increase during experimental hypovolemia
Alamandine attenuates hypertension and cardiac hypertrophy in hypertensive rats
Phosphodiesterase Langerhansscher Inseln
The inhaled phosphodiesterase 4 inhibitor GSK256066 reduces allergen challenge responses in asthma
Dual phosphodiesterase type 5 inhibitor therapy for refractory pulmonary arterial hypertension: a pilot study
Phosphodiesterase 10A upregulation contributes to pulmonary arterial hypertension
Role of Phosphodiesterase 5 and Cyclic GMP in Hypertension
Predictors of the response to phosphodiesterase-5 inhibitors in pulmonary arterial hypertension: an analysis of the Spanish registry
Inhibition of phosphodiesterase 5 restores endothelial function in renovascular hypertension
Mutant phosphodiesterase 3A protects from hypertension-induced end-organ damage
Lung vasodilatory response to inhaled iloprost in experimental pulmonary hypertension: amplification by different type phosphodiesterase inhibitors
Effect of a phosphodiesterase-5A (PDE5A) gene polymorphism on response to sildenafil therapy in canine pulmonary hypertension
Pulmonary hypertension attenuates the dynamic preload indicators increase during experimental hypovolemia
Alamandine attenuates hypertension and cardiac hypertrophy in hypertensive rats
Phosphodiesterase Langerhansscher Inseln
The inhaled phosphodiesterase 4 inhibitor GSK256066 reduces allergen challenge responses in asthma